Preterm infant fecal microbiota and metabolite profiles are modulated in a probiotic specific manner
Journal of Pediatric Gastroenterology and Nutrition 75.4 (2022): 535-542
Larke, Jules A., et al.
Tags: Inflammation Pre-term
In this single-center observational cohort study demonstrates that supplementing an HMO-catabolizing <em>Bifidobacterium</em> probiotic (<em>B. infantis</em> EVC001) results in increased microbial metabolism of milk oligosaccharides and reduced intestinal inflammation relative to a noncatabolizing Lactobacillus probiotic in human milk-fed preterm infants.
Related content in Publications
Frontiers in Nutrition 7 (2020): 33
Integrating the ecosystem services framework to define dysbiosis of the breastfed infant gut: the ro...Read more
FEMS Microbiology Letters 367.6 (2020): fnaa032
Reintroducing B. infantis to the cesarean‐born neonate: an ecologically sound alternative...Read more
Scientific Reports 11.1 (2021): 1472
Metagenomic insights of the infant microbiome community structure and function across multiple sites...Read more
Pediatric research 77.1 (2015): 229-235